• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Roles of tissue degenerative tansscriptional reprogramming in the evolution of head and neck cancer

Research Project

Project/Area Number 21K09576
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 56050:Otorhinolaryngology-related
Research InstitutionNational Hospital Organization, Kyushu Cancer Center

Principal Investigator

Muneyuki Masuda  独立行政法人国立病院機構(九州がんセンター臨床研究センター), その他部局等, 副院長 (90284504)

Project Period (FY) 2021-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2023: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2022: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2021: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
KeywordsYAP1 / エピジェネティクス / スーパーエンハンサー / 上皮間葉系転換 / 頭頸部癌 / epigenetics / super enhancer / 共生的進化 / 転写中毒 / 頭頸部癌進化 / 転写リプログラミング
Outline of Research at the Start

我々はこれまでに、頭頸部癌は、少数の遺伝子異常よりも、epigeneticに遺伝子発現プロフィールをリプログラミングしながら、環境ストレスに適応し進化する複雑適応進化系であるのもとで、研究を進めてきた。これまでに、YAP1による組織再生転写プログラムプが、この進化系の重要なドライビングフォースである事を示唆するデータを得ている。本研究ではこのメカニズムを包括的な手法により詳細に解析する。

Outline of Final Research Achievements

The mechanism by which YAP1 induces the onset and evolution of head and neck cancer was investigated and several novel findings were elucidated as follows.1.YAP1 activity (protein expression and super enhancer formation) significantly worsen the prognosis of patients.2.YAP1-associated super enhancer and IL6 form a feed forward loop. 3.PITX2 was identified as a novel partner transcription factor of YAP1.4.YAP1/ PITX2 super enhancer promotes lymph node metastasis through epithelial-mesenchymal transition

Academic Significance and Societal Importance of the Research Achievements

癌抑制遺伝子変異を主体とする頭頸部癌は現行の癌ゲノム医療の恩恵を受けていない代表的な癌腫である。本研究結果は頭頸部癌がYAP1の活性に強く依存していることを示しており、現在世界的に開発が進められているYAP1阻害剤の適応癌腫として有望であることを示している。

Report

(4 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • Research Products

    (21 results)

All 2023 2022 2021 Other

All Int'l Joint Research (3 results) Journal Article (7 results) (of which Peer Reviewed: 7 results,  Open Access: 7 results) Presentation (9 results) (of which Int'l Joint Research: 4 results,  Invited: 3 results) Book (1 results) Remarks (1 results)

  • [Int'l Joint Research] British Columbia University/Life Science Institute/Josef Penninger(カナダ)

    • Related Report
      2022 Research-status Report
  • [Int'l Joint Research] UC San Diego/Moores Cancer Center/Silvio Gutkind(米国)

    • Related Report
      2022 Research-status Report
  • [Int'l Joint Research] The British Columbia University/Life Science Institute/J Pennender, H Omori(カナダ)

    • Related Report
      2021 Research-status Report
  • [Journal Article] Inflammation-based Prognostic Score as a Prognostic Biomarker in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab Therapy2022

    • Author(s)
      Matsuo M, Yasumatsu R, Masuda M, Toh S, Wakasaki T, Hashimoto K, Jiromaru R, Manako T, Nakagawa
    • Journal Title

      In Vivo

      Volume: 36 Issue: 2 Pages: 907-917

    • DOI

      10.21873/invivo.12780

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Treatment Efficacy of PD-1 Inhibitor Therapy in Patients With Recurrent and/or Metastatic Salivary Gland Carcinoma2022

    • Author(s)
      HASHIMOTO KAZUKI、YASUMATSU RYUJI、KUGA RYOSUKE、HONGO TAKAHIRO、YAMAMOTO HIDETAKA、et al.
    • Journal Title

      Anticancer Research

      Volume: 42 Issue: 2 Pages: 981-989

    • DOI

      10.21873/anticanres.15558

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years2022

    • Author(s)
      MATSUO MIOKO、YASUMATSU RYUJI、MASUDA MUNEYUKI、YAMAUCHI MORIYASU、WAKASAKI TAKAHIRO、HASHIMOTO KAZUKI、JIROMARU RINA、MANAKO TOMOMI、NAKAGAWA TAKASHI
    • Journal Title

      In Vivo

      Volume: 36 Issue: 4 Pages: 1881-1886

    • DOI

      10.21873/invivo.12907

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Real-world Experience With Pembrolizumab for Advanced-stage Head and Neck Cancer Patients: A Retrospective, Multicenter Study2022

    • Author(s)
      NAKANO TAKAFUMI、YASUMATSU RYUJI、HASHIMOTO KAZUKI、KUGA RYOSUKE、HONGO TAKAHIRO、YAMAMOTO HIDETAKA、MATSUO MIOKO、WAKASAKI TAKAHIRO、JIROMARU RINA、MANAKO TOMOMI、TOH SATOSHI、MASUDA MUNEYUKI、YAMAUCHI MORIYASU、KURATOMI YUICHIRO、TAURA MASAHIKO、TAKEUCHI TORANOSHIN、NAKAGAWA TAKASHI
    • Journal Title

      Anticancer Research

      Volume: 42 Issue: 7 Pages: 3653-3664

    • DOI

      10.21873/anticanres.15854

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study2022

    • Author(s)
      Wakasaki Takahiro、Manako Tomomi、Yasumatsu Ryuji、Hara Hirotaka、Toh Satoshi、Masuda Muneyuki、Yamauchi Moriyasu、Kuratomi Yuichiro、Nishimura Emi、Takeuchi Toranoshin、Matsuo Mioko、Jiromaru Rina、Hashimoto Kazuki、Komune Noritaka、Nakagawa Takashi
    • Journal Title

      PLOS ONE

      Volume: 17 Issue: 7 Pages: 1-5

    • DOI

      10.1371/journal.pone.0271907

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Genetic and transcriptomic analyses in a rare case of human papillomavirus?related oropharyngeal squamous-cell carcinoma combined with small-cell carcinoma2021

    • Author(s)
      Sato Kuniaki、Nishiyama Kazuo、Taguchi Kenichi、Jiromaru Rina、Yamamoto Hidetaka、Matsunaga Akihide、Nagata Ryozaburo、Rikimaru Fumihide、Toh Satoshi、Higaki Yuichiro、Oda Shinya、Nakagawa Takashi、Masuda Muneyuki
    • Journal Title

      Molecular Case Studies

      Volume: 7 Issue: 5 Pages: a006102-a006102

    • DOI

      10.1101/mcs.a006102

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma2021

    • Author(s)
      Hongo T, Yamamoto H, Jiromaru R, Yasumatsu R, Kuga R, Nozaki Y, Hashimoto K, Matsuo M, Wakasaki T, Tamae A, Taguchi K, Toh S, Masuda M, Nakagawa T, Oda Y.
    • Journal Title

      Mod Pathol.

      Volume: 34 Issue: 11 Pages: 1966-1978

    • DOI

      10.1038/s41379-021-00868-w

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] YAP1-induced transcriptional reprogramming drives symbiotic evolution of head and neck cancer2023

    • Author(s)
      Masuda M, Omori H, Sato K, Nakano T, Penninger J, Gutkind JS
    • Organizer
      7thWorld Congress of the International Federation of Head and Neck Oncologie Societies
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Environment-induced YAP1 transcriptional reprogramming drives head and neck cancer2023

    • Author(s)
      Masuda M,OmoriH,Sato K,Nakano T,Penninger J,Gutkind S
    • Organizer
      AACR-AHNS Head and Neck Cancer Conference
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research
  • [Presentation] YAP1-induced transcriptional reprogramming drives symbiotic evolution of head and neck cancer2023

    • Author(s)
      Masuda M,OmoriH,Sato K,Nakano T,Penninger J,Gutkind S
    • Organizer
      AHNS 11thInternational Conference on Head & Neck Cancer
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Environment-induced YAP1 transcriptional reprogramming drives symbiotic evolution of head and neck cancer2023

    • Author(s)
      Masuda M,Omori H,Sato K,Nakano T,Penninger J,Gutkind,S
    • Organizer
      第82回日本癌学会学術総会
    • Related Report
      2023 Annual Research Report
  • [Presentation] Nationwide prospective study for the identification of nivolumab biomarkers via analyses of pre-treatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT2023

    • Author(s)
      Masuda M, Toh S, Sato K, Matsuo M, Sugasawa M, Yamazaki K, Ueki Y, Nakashima To, Uryu H, Ono T, Umeno H, Ueda T, Kano S, Tsukahara K
    • Organizer
      第61回日本癌治療学会学術集会
    • Related Report
      2023 Annual Research Report
  • [Presentation] YAP1-induced transcriptional reprogramming drives symbiotic evolution of head neck cancer2022

    • Author(s)
      Masuda M,Sato K,Omori H,Nakano T,Taguchi K,Penninger J
    • Organizer
      Cell Symposia
    • Related Report
      2022 Research-status Report
    • Int'l Joint Research
  • [Presentation] YAP1による転写リプログラミングは頭頸部癌共生的進化の推進力である2022

    • Author(s)
      大森裕文、佐藤晋彰、益田宗幸
    • Organizer
      第32回日本頭頸部外科学会総会ならびに学術講演会
    • Related Report
      2022 Research-status Report
    • Invited
  • [Presentation] 頭頸部扁平上皮癌でがんゲノム医療を機能させるためには2021

    • Author(s)
      益田宗幸
    • Organizer
      第72回日本気管食道科学会総会ならびに学術講演会
    • Related Report
      2021 Research-status Report
    • Invited
  • [Presentation] YAP1は頭頸部癌においてエピジェネティックリプログラミングを誘導する2021

    • Author(s)
      佐藤晋彰、中川尚志、益田宗幸
    • Organizer
      第80回日本癌学会学術総会
    • Related Report
      2021 Research-status Report
  • [Book] 頭頸部癌治療の新しい道2023

    • Author(s)
      益田宗幸、佐藤晋彰
    • Total Pages
      7
    • Publisher
      全日本病院出版会
    • Related Report
      2023 Annual Research Report
  • [Remarks]

    • URL

      https://lsi.ubc.ca/person/josef-penninger/

    • Related Report
      2021 Research-status Report

URL: 

Published: 2021-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi